Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  non-Hodgkin lymphoma
Stage/Subtype:  non-Hodgkin lymphoma
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-7 of 7 for your search:
Start Over
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 116428, NCI-2014-01414, 2012-003438-18, NCT01767467
Vaccine Therapy, Rituximab, Peripheral Blood Stem Cell Transplant, and Therapeutic Autologous Lymphocytes in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: LYMNHL0040-BMT212, NCI-2011-00136, 5089, 96940, NCT00490529
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
Vaccine Therapy in Treating Patients With Previously Treated Follicular Lymphoma
Phase: Phase I
Type: Treatment
Age: 40 and over
Trial IDs: 06-275, NCI-2010-00094, NCT00487305
Vaccine Therapy in Treating Patients with Lymphoplasmacytic Lymphoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0465, NCI-2012-01897, IBC-0804-098-RM-1, NCI-2010-02091, NCT01209871
Vaccine Therapy with or without Cryosurgery in Treating Patients with B-Cell Non-Hodgkin Lymphoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 70
Trial IDs: LS1081, NCI-2010-02003, 10-003023, NCT01239875
Start Over